Olaris CEO, Dr. Elizabeth O'Day, featured in DRG blog " Startup Scouring The Metabolome for Precision Medicine Biomarkers"

Want to learn more about Olaris and the power of metabolomics? Olaris CEO, Liz O'Day, discusses Olaris' platform and how metabolic biomarkers have the potential to change the way cancer is treated in the DRG blog.

February 6, 2020

Olaris CEO, Dr. Elizabeth O'Day, featured in DRG blog " Startup Scouring The Metabolome for Precision Medicine Biomarkers"